Concepedia

Publication | Closed Access

Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes

DOI

503

Citations

34

References

2011

Year

John B. Buse, Richard M. Bergenstal, Leonard C. Glass, Cory R. Heilmann, Michelle S. Lewis, Anita Y. M. Kwan, Byron J. Hoogwerf, Julio Rosenstock
Annals of Internal Medicine

Abstract

Alliance of Eli Lilly and Company and Amylin Pharmaceuticals.

References

YearCitations

Page 1